Press-release for stocks for INVO

Prices are updated after-hours

symbols : INVO

save search

INVO Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| Email alert Add to watchlist
year financial results

Assisted Reproductive Technology (ART) Market 2023-2027 | US$ 8.23 billion growth is expected between 2022 to 2027 | Rising infertility rates and obesity-linked cases to boost growth
Published: 2024-02-12 (Crawled : 03:00) - prnewswire.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| 27.17% | O: 2.17% H: 0.0% C: -4.26%
expected technology growth market

NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)
Published: 2024-01-23 (Crawled : 15:30) - biospace.com/
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| 13.59% | O: 3.88% H: 9.35% C: 2.8%
acquire program therapy

INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
Published: 2024-01-17 (Crawled : 15:30) - biospace.com/
NBTX | $5.71 1.04% 1.4K

Manufacturing

| -24.74% | O: -0.51% H: 0.0% C: -0.77%
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -9.53% | O: -1.83% H: 0.0% C: 0.0%
VIRX | $0.8367 -1.31% -1.33% 55K

Manufacturing

| 55.27% | O: -0.18% H: 0.0% C: -3.33%
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| 11.43% | O: 5.71% H: 10.81% C: 6.31%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -8.51% | O: -1.02% H: 0.0% C: 0.0%
SLN | $22.33 -0.8% -0.81% 110K

Health Technology

| 24.76% | O: -1.62% H: 3.08% C: 2.96%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -8.18% | O: 0.45% H: 0.06% C: -0.5%
ORTX | $16.7 0.0% 370K

Health Technology

| 1.16% | O: -0.3% H: 0.98% C: 0.98%
KYMR | $35.18 -1.48% -1.51% 380K

Health Technology

| 24.81% | O: -2.8% H: 5.11% C: 1.42%
bioscience

NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology’s Blood Journal
Published: 2023-12-11 (Crawled : 13:30) - invobioscience.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| -18.18% | O: -4.2% H: 4.64% C: 1.46%
cd38 antibody publication blood

NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies
Published: 2023-12-06 (Crawled : 14:30) - invobioscience.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| -26.42% | O: 1.26% H: 5.59% C: 1.86%
partnership natural cell research therapeutics therapy

INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
Published: 2023-11-28 (Crawled : 15:00) - invobioscience.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| -43.75% | O: -4.33% H: 2.51% C: -8.04%
nasdaq bioscience

INVO Reports Record Third Quarter 2023 Financial Results
Published: 2023-11-13 (Crawled : 22:00) - invobioscience.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| -27.33% | O: 26.09% H: 21.67% C: 6.4%
financial results

NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger
Published: 2023-11-10 (Crawled : 14:30) - invobioscience.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| 70.31% | O: 89.23% H: 56.92% C: 0.77%
bioscience

INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company’s Common Stock Purchase Warrants
Published: 2023-11-09 (Crawled : 22:00) - invobioscience.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| 70.31% | O: 89.23% H: 56.92% C: 0.77%
bioscience

The Assisted Reproductive Technology Market size to grow at a CAGR of 5.79% from 2022 to 2027- Technavio
Published: 2023-10-30 (Crawled : 19:00) - prnewswire.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| -11.36% | O: -2.27% H: 11.63% C: -3.1%
technology market

INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company
Published: 2023-10-23 (Crawled : 12:00) - invobioscience.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| 116.67% | O: 174.07% H: 105.41% C: 43.24%
company life bioscience agreement

INVO to Participate in the Lytham Partners Fall 2023 Investor Conference
Published: 2023-10-11 (Crawled : 13:30) - invobioscience.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| 72.31% | O: 4.99% H: 0.0% C: -14.43%
conference

INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS
Published: 2023-09-29 (Crawled : 21:00) - invobioscience.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| Email alert Add to watchlist
bioscience meeting

INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET
Published: 2023-09-28 (Crawled : 17:00) - invobioscience.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| 37.65% | O: -10.59% H: 17.75% C: 12.51%
meeting

IVF Disposables Market to grow by USD 248.53 million from 2022 to 2027 | North America to account for 38% of market growth- Technavio
Published: 2023-09-27 (Crawled : 03:00) - prnewswire.com
TPST | $3.43 0.29% 0.29% 650K

Manufacturing

| 882.3% | O: -0.06% H: 0.0% C: -2.86%
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| 36.84% | O: -3.09% H: 3.79% C: 2.58%
TMO | News | $577.39 0.49% 0.0% 2M

Health Technology

| 14.68% | O: -0.17% H: 0.39% C: -0.86%
AMCR | $9.06 0.89% 0.0% 5.8M

Process Industries

| -0.44% | O: 0.33% H: 0.33% C: -1.1%
america market

The Assisted Reproductive Technology Market size to grow at a CAGR of 5.79% from 2022 to 2027; The increase in awareness of ART to boost the market growth - Technavio
Published: 2023-08-15 (Crawled : 00:00) - prnewswire.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| -17.89% | O: -4.56% H: 8.09% C: 4.41%
technology growth market

INVO Reports Second Quarter 2023 Financial Results
Published: 2023-08-14 (Crawled : 20:00) - prnewswire.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| -30.77% | O: -4.73% H: 1.24% C: -11.49%
financial results

INVO Bioscience Announces Closing of $4.5 Million Public Offering
Published: 2023-08-08 (Crawled : 18:00) - prnewswire.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology

| -37.77% | O: 0.0% H: 11.12% C: 2.66%
bioscience offering

INVO Bioscience Announces Pricing of $4.5 Million Public Offering
Published: 2023-08-04 (Crawled : 13:00) - prnewswire.com
INVO | $1.16 -10.77% -12.07% 400K

Health Technology